Mimedx (MDXG) Net Equity Issued and Repurchased (2011)

Mimedx (MDXG) reported Net Equity Issued and Repurchased of -$3.7 million for Q4 2011, down 3476.65% sequentially from $110867.0 in Q3 2011.

Mimedx (MDXG) Net Equity Issued and Repurchased (2011) Analysis & Trends

Mimedx (MDXG) has 1 years of Net Equity Issued and Repurchased data on file, last reported at -$3.7 million in Q4 2011.

  • For the quarter ending Q4 2011, Net Equity Issued and Repurchased changed N/A year-over-year to -$3.7 million; the trailing twelve-month figure through Sep 2012 stood at -$3.7 million (changed N/A YoY), and the FY2020 full-year result was $100.0 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased eased to -$3.7 million in Q4 2011, from $110867.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $2.4 million in Q2 2011 to a low of -$3.7 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 141.90 Mn
10 Mimedx 635.35 Mn 475.58 Mn 41.62 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 -3.74 Mn
Dec 31, 2011 -3.74 Mn
Sep 30, 2011 110,867.00
Sep 30, 2011 110,867.00
Jun 30, 2011 2.42 Mn
Jun 30, 2011 2.42 Mn
Mar 31, 2011 1.21 Mn
Mar 31, 2011 1.21 Mn